← Evidence map

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2023

Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer's disease treatment.

Jinwei ZhangPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 37682322